Background {#Sec1}
==========

Trauma induces a widespread neurohumoral stress response. This results in changes in the balance between anabolic (growth) and catabolic (destructive) functions within the body. This has many effects, including increased catabolism, release of pro-inflammatory cytokines and activation of the sympatho-adrenal system.

Insulin resistance (IR) is believed to be a fundamental component regulating the change in the balance between anabolism and catabolism \[[@CR1]\].

Insulin resistance is a metabolic state of reduced hepatic and peripheral (mainly muscle) responsiveness to insulin. Chronically, around 85% of Type II diabetics and 20% of non-diabetic individuals have biochemically defined insulin resistance \[[@CR2]\]. In the peri-operative period, insulin resistance has a rapid onset \[[@CR3]\], is predominantly of muscle origin and persists for a considerable period (weeks) following surgery. It appears to be, at least in part, a response to trauma and reduced energy intake \[[@CR4]\].

The severity of insulin resistance is directly proportional to the magnitude of the surgical insult. It is also related to the development of postoperative complications \[[@CR5]\]. Insulin resistance occurs in parallel with multiple other metabolic effects including decreased muscle carbohydrate oxidation, increased muscle catabolism, negative nitrogen balance, reduced muscle mass \[[@CR6]\] and reduced muscle strength \[[@CR7]\]. It is possible that they share a common signalling pathway.

There has been considerable work investigating the effect of differing forms of anaesthesia and surgery on the quality of this stress response. Minimally invasive surgery reduces, but does not eliminate, the stress response, and the beneficial effects may be dependent upon the type of surgery \[[@CR8]\]. Regional anaesthesia, if complete, may abolish the adrenocortical, glycaemic and some of the inflammatory responses, but it does not abolish all of the cytokine responses to tissue trauma \[[@CR9]\]. It has not been shown to improve outcome following hip fracture \[[@CR10]\].

In recent years, a whole system approach to ameliorating the response to surgery has been introduced. The 'Enhanced Recovery after Surgery' approach (ERAS) aims to minimise all aspects of the surgical pathway that might impede recovery. Individual components of the bundle are of benefit with regard to surrogate and/or clinical outcomes. As a whole, the bundle has been associated with improved outcomes in a meta-analysis of randomised studies \[[@CR11]\]. These studies, however, have only involved elective patients.

Carbohydrate loading {#Sec2}
--------------------

The traditional approach to pre-operative preparation of patients involves a relatively prolonged period of pre-operative food and water starvation. This has been done to reduce the real, though small, risks of pulmonary aspiration of stomach contents. More recently it has been recognised that this approach induces the body's starvation response. This may then be exacerbated by the catabolic effects of surgery. Several groups have demonstrated the beneficial effects of mitigating this by providing patients with carbohydrate drinks the evening before and morning of surgery.

Some of the beneficial effects seen in humans include reductions in insulin resistance and hyperglycaemia \[[@CR12]\], postoperative nausea and vomiting \[[@CR13]\], pre-operative discomfort \[[@CR14]\] and preservation of muscle mass \[[@CR15]\].

There is reasonable evidence for the safety of carbohydrate drinks \[[@CR16]\]. Studies in volunteers \[[@CR17]\], cardiac and general surgical \[[@CR18]\] patients have not demonstrated increased gastric volumes when such drinks are given up to two hours before surgery.

Studies of oral carbohydrate loading have demonstrated a reduction in insulin resistance of approximately 50% in elective orthopaedic, colorectal and laparoscopic surgery \[[@CR19]\], and the effect appears to be prolonged \[[@CR8], [@CR12], [@CR16]\].

It is apparent that being in the fed versus the fasted state improves outcome following surgical stress; however, the exact reason for this is unclear. By avoiding depletion of liver glycogen reserves, there is a more rapid release of glucose from the liver into blood. Animal studies suggest that this results in a hyperosmolar state with possible benefits in fluid distribution and cardiovascular performance \[[@CR19]\]. It may also affect immune function and reduce muscle protein catabolism, thereby maintaining muscle performance.

During the early phase of postoperative insulin resistance, the main defect is in the process of glucose uptake into the muscle. Specific glucose transporters (GLUT4) are not activated in the normal way by the action of circulating insulin \[[@CR20]\].

More recent work has shown that the intracellular signalling systems that activate GLUT4, including PI-3-kinase, are downregulated while other signalling systems, which activate the inflammatory responses, are upregulated both in muscle \[[@CR21]\] and fat tissue \[[@CR22]\]. Animal work from the laboratory of one of the authors has demonstrated that a systemic inflammatory response increases the expression of pro-inflammatory cytokines in muscle, resulting in impaired PI-3-kinase signalling and the activation of downstream transcription FOXO factors. This has the effect of increasing the expression of muscle pyruvate dehydrogenase kinase 4 and muscle atrogene mRNA and protein. Collectively, these molecular responses impair muscle pyruvate dehydrogenase complex activation and carbohydrate use, as well as increasing proteasomal and cathepsin L activity and thereby muscle protein loss \[[@CR23]\]. Translation of these findings has revealed that the same molecular events occur in intensive care patients \[[@CR24]\] who are known to be insulin resistant. Furthermore, carbohydrate loading resulted in a reduction in the peri-operative induction of PDK4 mRNA, which inhibits oxidative carbohydrate metabolism \[[@CR25]\].

These alterations in molecular signalling secondary to surgical stress are associated with a host of negative physiological effects postoperatively such as impaired glucose tolerance, decreased mitochondrial ATP production, increased gut permeability, increased free circulating fatty acids, decreased muscle glycogen levels and increased levels of blood lactate \[[@CR26], [@CR27]\].

Furthermore, it has been shown that increased muscle PDK4 expression inhibits the activity of pyruvate dehydrogenase complex (PDC), which controls the rate of muscle carbohydrate (CHO) oxidation in mitochondria. It is theorised that impaired PI3K/Akt1/FOXO signalling and the resultant upregulation of PDK4 are important factors underlying the development of muscle insulin resistance \[[@CR28], [@CR29]\].

Muscle metabolism {#Sec3}
-----------------

Muscle metabolism and function is fundamental to postoperative recovery. Previous research on muscle metabolism following trauma and acute illness has largely focussed on organ-level changes in nitrogen balance and glucose metabolism. More recently research into the acute effects of illness on the transcriptional pathways involved in muscle homeostasis have shown that the changes are not a simple on/off phenomenon with some evidence of balancing anabolic processes being switched on shortly after the onset of sepsis. Although basal muscle metabolism is unaffected by age, the ability to incorporate amino acids following food may be different in the elderly \[[@CR30]\] -- so-called anabolic resistance.

Our study will investigate whether pre-operative CHO feeding has the ability to counter the cytokine mediated impairment of Akt phosphorylation caused by surgical stress, ultimately reducing the degree of insulin resistance.

Hip fracture {#Sec4}
------------

Fragility hip fracture is a very significant burden to patients, carers and the health service \[[@CR31]\]. Patients with fragility hip fracture have a poor outcome in terms of mortality and functional recovery \[[@CR32], [@CR33]\]. They also have a considerable hospital and rehabilitation length of stay. Early mobility is associated with better outcome \[[@CR34]\], and the degree of mobility following discharge is linked to late mortality \[[@CR35]\]. General muscle strength (not just lower limb strength) is associated with degree of functional recovery following hip fracture \[[@CR36]\].

Careful multi-disciplinary pre-operative assessment and optimisation for surgery has been shown to improve functional outcomes and mortality. However, recent NICE guidance does not include the requirement for nutritional assessment. There is some evidence that nutritional intervention as part of a comprehensive hip fracture programme improves outcomes \[[@CR37]\], and may reduce postoperative complications \[[@CR38]\]. There are however no metabolic studies investigating pre-operative carbohydrate loading in this patient group.

There are few data regarding the stress response in the very elderly (the median age of hip fracture patients is approximately 84 years). Kudoh and colleagues \[[@CR39]\] demonstrated differences between the very elderly and younger patients undergoing hip fracture surgery with regard to norepinephrine and cortisol responses, though the lack of analgesia in this study raises questions over relevance to modern practice. Pro-inflammatory cytokine responses appear to be augmented in the very elderly \[[@CR40]\]. Sun and colleagues demonstrated a rise in plasma concentrations of pro-inflammatory cytokines following admission with hip fracture in the elderly, and the magnitude of this response was predictive of 6 month and 12 month mortality \[[@CR41]\]. Studies of insulin resistance have had few or no patients over 80 \[[@CR42], [@CR43]\].

Qualitatively, the hormonal response following minor surgery appears similar in younger and in older (70 to 75 years) patients \[[@CR44], [@CR45]\]. Previous researchers have demonstrated an early and persisting loss of muscle mass following hip fracture \[[@CR46]\], which may be one reason for the decline in function and persistent insulin resistance seen following injury. These data would suggest that if practical strategies to reduce insulin resistance were available, there may be possible outcome benefits for patients following hip fracture.

Previous studies using pharmacological modulation of muscle metabolism in this patient group have shown conflicting results. Studies using human growth hormone or similar drugs have reported increased side effects in the treatment groups \[[@CR47], [@CR48]\].

Postoperative nutritional supplementation has had some favourable results \[[@CR49]\] but has suffered with poor compliance. A Cochrane review of nutritional supplementation found only weak evidence of benefit \[[@CR50]\]. One reason for this may be that the intervention is insufficient in patients who are already in a catabolic state after surgery. Pre-surgical intervention may not only provide nutrition but also modulate the catabolic response.

There has been a relatively successful national drive to reduce the time between admission and surgery for patients with hip fracture. According to the latest results from the National Hip Fracture Database 2013 71.4% of patients received their operation within 36 hours \[[@CR51]\]. Nonetheless, this still provides a considerable period when patients may be kept nil by mouth awaiting operation. Accurate data for true starvation periods are scarce. A small audit from a UK District General Hospital found 'average' starvation times after 7 am of 4 to 6 hours, which should be added to the 7 hours from midnight \[[@CR52]\]. Although most patients are now given intravenous rehydration whilst waiting for theatre, food is less commonly given and nausea is a common complication of the injury, pain and the opioids given for analgesia.

There is a small amount of evidence of impaired glucose homeostasis in hip fracture patients. Liu found evidence of postoperative hyperglycaemia in around 70% of patients \[[@CR41]\]. Around 40% of patients from the recently completed NOTTS study \[[@CR53], [@CR54]\] are hyperglycaemic prior to induction of anaesthesia.

However, the evidence from elective surgery may not be directly applicable to hip fracture patients. First, by definition, these patients have already suffered one traumatic insult (the injury) so the catabolic processes may have already begun. Second, the carbohydrate loading studies have generally used an 800-ml drink the night before surgery and a 200-ml drink on the morning of surgery. Although this is well tolerated in elective surgical patients, it may not be so well tolerated by frail elderly patients. Third, approximately 50% of hip fracture surgery is performed under spinal anaesthesia \[[@CR51]\]. There is some evidence from elective surgery that this may diminish the impact of carbohydrate loading, presumably due to the reduction in the stress response.

Methods/Design {#Sec5}
==============

Study objectives {#Sec6}
----------------

### Primary aims {#Sec7}

To investigate whether pre-operative carbohydrate loading (using Nutricia pre-op drinks) results in an improvement in insulin resistance in patients undergoing hemiarthroplasty for a fragility fracture of the neck of femur.

### Secondary aims {#Sec8}

Does pre-operative carbohydrate loading in elderly hip fracture patients have other benefits in the post-operative period? The following will be evaluated to determine this:Muscle metabolism.Functional mobility (measure with the Cumulative Ambulation Score).Infectious/cardiovascular complications.Length of acute hospital stay.

Study design {#Sec9}
------------

This is a prospective, parallel group, double-blind (participant and investigators), randomised controlled clinical trial.

Two centres will participate: Queen's Medical Centre campus of Nottingham University Hospitals and Pilgrim Hospital, United Lincolnshire Hospitals, Boston.

Recruitment started in September 2014, and total recruitment in expected to take 12 to 18 months.

Randomisation and blinding {#Sec10}
--------------------------

Randomisation (on a one-to-one basis) will be provided by a password-protected web-based randomisation service, with sequence not revealed until data lock. Participants will be randomised after x-ray confirmation of a displaced intracapsular fracture of the neck of femur and appropriate assessment and counselling from a member of the research team.

The investigators, patient, nurses and data-collection staff will all be blinded to treatment allocation. Drinks will be prepared by a separate member of staff who will not be blinded for practical reasons but who will not take part in any aspect of the study apart from preparation of the drinks.

The assessment of Cumulative Ambulation Score will be made by the ward physiotherapists treating the patient. The multiprofessional team makes the decision that a patient is medically fit for discharge when all are satisfied that the participant has no ongoing needs for acute hospital care. This team is blinded to participant allocation.

Selection and withdrawal of participants {#Sec11}
----------------------------------------

### Recruitment {#Sec12}

Participants will be identified by nurses in the Emergency Department, who will then inform a member of the research team about the presence of the patient. Once a patient has been identified, a member of the research team will approach the patient and conduct the initial screening and consenting of the patient. Active participation in the study will be until the second glucose tolerance test has been performed 24 hours after surgical fixation.

Participants will be informed that participation is voluntary and that they are free to withdraw at any time without affecting their care.

Data on time to discharge and mortality are routinely collected on all hip fracture patients at each institution, and participation in the trial will involve consent for this data to be used.

Patients unable to provide informed consent will be excluded from the trial. Patients for whom language will be a barrier will also be excluded due to the small scale nature of the study. Patient information will not be available in languages other than English. In practice, non-English speakers represent a very small number of patients in this population group.

Inclusion criteria {#Sec13}
------------------

Inclusion criteria include the following:Primary hip fracture listed for surgical repair using hemiarthroplasty.Age over 70 years.Able to give informed consent.

Exclusion criteria {#Sec14}
------------------

Exclusion criteria include the following:Pre-existing diabetes (type I or II).Intercurrent infection.Ongoing participation in another interventional clinical trial.Previous intolerance to carbohydrate drinks.Any condition or impairment, which, in the view of the investigator, would prohibit the patient from full participation in the study.

Informed consent {#Sec15}
================

Informed consent is obtained from every participant. The capacity for providing consent is assessed routinely by the orthopaedic team, which decides whether the patient is competent to provide consent for the surgical procedure. If the orthopaedic team deems the patient unable to consent to surgery, then the patient will be deemed incapable of consenting to enter the study. A member of the research team also performs an additional check of the participant's ability to provide consent immediately prior to starting the study. All members of the research team are trained at obtaining consent in accordance with guidance for good clinical practice \[[@CR55]\].

The trial received favourable ethical approval from the NRES Committee East Midlands-Nottingham 1 on 15 July 2013.

Study intervention {#Sec16}
------------------

All patients enrolled into the trial will receive a baseline glucose tolerance test a minimum of four hours after their last oral intake. Routine practice at both study centres is to place patients with diagnosed hip fractures nil by mouth until an operating theatre time is identified. Once this test is performed patients allocated to the active group will receive 400 ml of carbohydrate drink (Nutricia Pre-op). Patients in the control arm will receive 400 ml of diet (sugar free) lemon drink. This will be administered by the investigator from an opaque jug to reduce identification of the drink. A further 400 ml of either carbohydrate drink or of placebo will be administered by nursing staff at 06:00 hours on the morning of surgery. This is to allow a minimum of two hours fasting pre-operatively, which is standard policy at both sites.

Three muscle biopsies will be performed in total, taken from the *vastus lateralis*: one after anaesthesia but before surgery in the non-fractured leg, with sample two being taken after wound closure but before wake up (for general anaesthesia) or resolution of regional anaesthesia. The third muscle biopsy will be taken 24 hours after the end of surgery at approximately the same time as the second glucose tolerance test. All muscle biopsies will be snap frozen in liquid nitrogen and stored at -80°C before transport to the muscle physiology laboratory for analysis.

Standard care {#Sec17}
-------------

Standard care will be identical in both groups. Only the administration of the carbohydrate drink will differ between groups.

All patients are admitted to dedicated trauma wards and cared for in accordance with UK 'Best Practice Tariff' \[[@CR56], [@CR57]\].

This includes assessment by orthogeriatricians, operation within 36 hours of admission, and assessment of bone health and falls. All patients are cared for under a hip fracture care pathway, which involves rapid assessment and admission from the emergency department, intravenous crystalloid infusions from the time of admission, and multiprofessional care and discharge planning. Operations are performed in dedicated trauma theatres by appropriately experienced surgeons and anaesthetists.

The surgical stress response *per se* generates insulin resistance; therefore the protocol does not allow a *de novo* diagnosis of diabetes. However, glucose tolerance test results will be available to the clinical team to make appropriate clinical decisions.

Concomitant medication {#Sec18}
----------------------

Analgesia will be provided in accordance with normal practice at the study centre. Non-steroidal anti-inflammatory drugs are not routinely prescribed for this group of patient due to their side effects. Other medications will be prescribed by the attending medical staff as appropriate for each individual.

Concomitant treatments {#Sec19}
----------------------

Anaesthesia will be at the discretion of the attending anaesthetist. Other post-operative therapies such as physiotherapy will be in accordance with routine hospital practice at the relevant centre.

Laboratory analysis {#Sec20}
-------------------

Glucose tolerance test blood will be analysed on a bedside blood glucose analyser (Hemocue, Brea CA, USA). C-peptide and insulin levels, along with all muscle biopsy samples, will be analysed by Professor Greenhaff's team at the MRC-ARUK Centre for Musculoskeletal Ageing Research, University of Nottingham.

Muscle metabolism {#Sec21}
-----------------

Laboratory analysis will be performed by Professor Greenhaff's team at the School of Biomedical Sciences University of Nottingham. This will include PCR/western blot and spectrophotometric analysis. The following parameters will be examined:TNF / IL6 mRNA expression, extent of activation of inflammatory processes, assessed using real-time PCR.AKT protein phosphorylation-phosphorylates FOXO, leading to decreased FOXO activity, assessed using western blotting.FOXO 1 and 3 protein phosphorylation, induces PDK4 transcription, assessed using western blotting.PDK 2 and PDK4 (pyruvate dehydrogenase lipoamide kinase isozyme 4) mRNA and protein expression, muscle-specific isoform known to inhibit PDC activation, assessed using real-time PCR and western blotting.Glycogen, muscle store of carbohydrate, assessed using spectrophotometry.PDC (pyruvate dehydrogenase complex) protein activation status, rate limiting enzyme for mitochondrial carbohydrate oxidation, assessed using a radioimmunoassay.

Discussion {#Sec22}
==========

This is a small-scale pilot study. Preoperative carbohydrate loading has been shown to be effective in suppressing the insulin resistance that develops in other postsurgical populations, but its use has never been investigated in an emergency hip fracture population.

Carbohydrate loading is a relatively cheap intervention with little or no side effects which, if shown to be of benefit, could be rolled out across the whole patient population and included as part of an emergency hip fracture enhanced recovery programme. Conversely, it may be of little benefit and resources could be directed elsewhere. The secondary data on the metabolic effects of trauma in the elderly will provide important insights into ageing physiology that will be of increasing importance as the population demographic changes.

It is hoped that if this study shows positive effects, it will serve as a guide for larger studies investigating carbohydrate loading in emergency patients.

Trial status {#Sec23}
------------

NUH NHS R and I approval was gained on 24 April 2014

The trial started recruiting September 2014.
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